Financhill
Sell
45

STOK Quote, Financials, Valuation and Earnings

Last price:
$9.73
Seasonality move :
-9.43%
Day range:
$9.34 - $9.83
52-week range:
$5.35 - $17.58
Dividend yield:
0%
P/E ratio:
11.94x
P/S ratio:
2.82x
P/B ratio:
1.47x
Volume:
464.9K
Avg. volume:
753.9K
1-year change:
-29.34%
Market cap:
$514.8M
Revenue:
$36.6M
EPS (TTM):
$0.79

Earnings Data

Next earnings date for STOK
Aug 07
2025
Most recent earnings per share
$1.90
Beat by $1.99
(May 13/2025)
Consensus Estimate
-$0.09
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STOK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/07/2025 Q2 $10M -- -- -$0.47 --
05/13/2025 Q1 $31.5M $158.6M $1.90 -$0.09 $1.99
03/18/2025 Q4 $4.3M $22.6M -$0.18 -$0.53 $0.35
11/05/2024 Q3 $3.6M $4.9M -$0.47 -$0.54 $0.07
08/07/2024 Q2 $3.3M $4.8M -$0.46 -$0.56 $0.10
05/06/2024 Q1 $3.2M $4.2M -$0.57 -$0.61 $0.04
03/25/2024 Q4 $3.2M $2.8M -$0.60 -$0.63 $0.03
11/07/2023 Q3 -- -- -$0.55 -$0.65 $0.10
08/07/2023 Q2 -- -- -$0.69 -$0.66 -$0.03
05/04/2023 Q1 -- -- -$0.53 -$0.72 $0.19
03/10/2023 Q4 -- -- -$0.65 -$0.71 $0.06
11/14/2022 Q3 -- -- -$0.66 -$0.68 $0.02
08/08/2022 Q2 -- -- -$0.63 -$0.69 $0.06
05/10/2022 Q1 -- -- -$0.66 $0.13 -$0.79
03/10/2022 Q4 -- -- -$0.66 -$0.61 -$0.05
11/08/2021 Q3 -- -- -$0.61 -$0.55 -$0.06
08/10/2021 Q2 -- -- -$0.60 -$0.46 -$0.14
05/10/2021 Q1 -- -- -$0.46 -$0.44 -$0.02
03/09/2021 Q4 -- -- -$0.42 -$0.42 $0.00
11/12/2020 Q3 -- -- -$0.41 -$0.43 $0.02
08/10/2020 Q2 -- -- -$0.39 -$0.36 -$0.03
05/15/2020 Q1 -- -- -$0.34 -$0.37 $0.03
03/23/2020 Q4 -- -- -$0.31 -$0.30 -$0.01
11/12/2019 Q3 -- -- -$0.26 -$0.28 $0.02
08/14/2019 Q2 -- -- -$1.54 -$1.63 $0.09

Stoke Therapeutics Earnings Questions

  • How Much did Stoke Therapeutics Generate in Revenue Last Quarter?

    Stoke Therapeutics reported $158.6M worth of top line sales in its most recent quarter.

  • Did Stoke Therapeutics Beat Earnings Last Quarter?

    Stoke Therapeutics announced earnings per share of $1.90 which represents a beat of analyst forecast a -$0.09 per share.

  • Is Stoke Therapeutics Profitable?

    Stoke Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Stoke Therapeutics EPS Next Year?

    Stoke Therapeutics's earnings are forecast to decrease from -$1.65 per share to -$2.02 per share next year representing a decrease of -18.46%.

  • When is Stoke Therapeutics's Earnings Date?

    Stoke Therapeutics's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Cameco Stock Be in 5 Years?
Where Will Cameco Stock Be in 5 Years?

Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…

Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth

Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
73
CTEV alert for May 30

Claritev [CTEV] is up 34.96% over the past day.

Buy
87
ELF alert for May 30

e.l.f. Beauty [ELF] is up 23.68% over the past day.

Buy
67
BBW alert for May 30

Build-A-Bear Workshop [BBW] is up 21.83% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock